Novel Biome is Canada’s first fecal microbiota transplant (FMT) manufacturer to hold a Drug Establishment Licence from Health Canada. The company produces FMT capsules, enemas and vials from rigorously screened human donors and supplies them only to licensed practitioners and clinics internationally. Novel Biome supports its clinic partners with protocol guidance, donor screening documentation and dedicated practitioner accounts, helping integrative providers bring microbiome restoration into their practice. The company is also building outcome data to help advance the science of FMT.